Navigation Links
Prescription Sleeping Pill Use Tied to Cancer
Date:8/18/2008

ypnotics cause cancer."

But both he and Friedman -- who congratulated Kripke for raising this important issue even though the reviewer remained somewhat skeptical of a causal link -- urge caution and suggest that regulatory bodies and the U.S. National Institutes of Health keep an eye on cancer cases reported by sleeping pill users.

The Journal of Sleep Research is published by Wiley-Blackwell and can be accessed online at http://www.blackwellpublishing.com/jsr

ABOUT SCRIPPS CLINIC

Founded in 1924, Scripps Clinic is a multi-specialty, outpatient care facility caring for patients at multiple locations throughout San Diego County including Torrey Pines, Del Mar, Encinitas, La Jolla, Mission Valley, Rancho Bernardo, Rancho San Diego and Santee. Scripps Clinic and its physicians are world-renown for research-driven care and medical specialty expertise and is an operating unit of Scripps Health, a not-for-profit, community-based health care delivery network that includes more than 2,600 affiliated physicians, five acute-care hospitals, home health care and associated support services. Scripps Health is one of the largest health care organizations in San Diego County, drawing from the expertise of more than 10,000 health care professionals.

HIGHLIGHTS:

A researcher at Scripps Clinic has published an article in the Journal of Sleep Research indicating that people who use popular prescription sleeping pills are more likely to develop cancer than those who do not use sleeping pills.

AVAILABLE FOR INTERVIEWS:

-- Daniel Kripke, M.D., study author, Co-Director for Research, Scripps Clinic Sleep Center


'/>"/>
SOURCE Scripps Clinic
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
2. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Novel Technology Breaks Through Cancer Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...y switch that, if turned off, causes lymphatic end...e their identity and become more like blood endoth...ewswire-USNewswire/ -- Scientists at St. Jude Chi...ertain differentiated cell type is so ready to cha...ression of a gene called Prox1 to dissuade it. ...
(Date:12/1/2008)...Call/ -- Genaera Corporation (Nasdaq: GENR ) to... study MSI-1436C-102 (Study 102), the multiple asc...436) in overweight and obese type 2 diabetics. MSI...type 2 diabetes and obesity which works centrally ...thways through the highly selective inhibition of ...
(Date:12/1/2008)...ber 9 at 11:00 am ET to Discuss Phase 2 Study Resu...if., Dec. 1 Sunesis Ph...ceutical company focused on the development and co...y announced new data from its studies of voreloxin... during the 50th American Society of Hematology (A...
(Date:12/1/2008)...al Incorporated (Nasdaq: VICL ) announced today ...om Merck & Co., Inc. based on Merck,s planned ...tigational plasmid DNA (pDNA) cancer vaccine. The ...ivery technology and encodes human telomerase reve... separate license agreement. , , "The bread...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Vitamin D and breast cancer risk 17194 1Vitamin D and breast cancer risk 17194 2Study finds patients overestimate cancer screening history 17192 1Study finds patients overestimate cancer screening history 17192 2Woodland Park Care Center Earns Quality Respiratory Care Recognition 17190 1Woodland Park Care Center Earns Quality Respiratory Care Recognition 17190 2Huifeng Bio Pharmaceutical 28HFGB 29 Announces Participation in the 59th PHARMCHINA Expo 17188 1Huifeng Bio Pharmaceutical 28HFGB 29 Announces Participation in the 59th PHARMCHINA Expo 17188 2
...Professor Home said: , "The editorials published b...t they disregarded important pieces of data that,a...Most,significantly the editorials ignored data tha...ular death or death from any,cause." , Professor P...778-525-1736 , Terms and conditions of use apply ...
...ief within 5,minutes of dosing and is well-tolerat...arma Ltd,("Archimedes"), a European specialty phar...ata from a Phase II study of Nasalfent(r),an inno...ding a,fast, effective and convenient treatment fo... the 10th Congress of the European,Association for...
Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3
(Date:12/1/2008)... ETHICON, Inc., a Johnson & J...ted the divestiture of its Professional Wound Care... of the transaction are not being disclosed. , ...ty Partners has acquired the Professional Wound Ca... wound care brands as PROMOGRAN Matrix Wound Dress...
(Date:12/1/2008)...h the agency,s goals, commitment and resources ,...sponding to criticism that it has done a poor job ...od and Drug Administration released a report Monda... Among the most important changes in 2008 was the ...with state and local health departments to protect...
(Date:12/1/2008)...The Arthritis Foundation announces the 2008 winner...rthritis. The recipients, Dr. Gerard Karsenty of t...r. Michel Nussenzweig of Rockefeller University re...ncements in the cure and control of rheumatic dise...arch in the development and function of the skelet...
(Date:12/1/2008)...wswire-USNewswire/ -- Americans United for Life ... legislative resolution opposing the federal "Free...atures to adopt the resolution immediately when th...rmaine Yoest, AUL President & CEO said, "The s... health. It protects and promotes the abortion in...
Breaking Medicine News(10 mins):Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 3Health News:FDA Touts Efforts to Enhance Food Safety 2Health News:FDA Touts Efforts to Enhance Food Safety 3Health News:FDA Touts Efforts to Enhance Food Safety 4Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2
...ohn's disease do not have improved bone mineral de... vitamin D therapy. Crohn's is an inflammatory bow...the intestinal wall. It usually begins in the teen...iarrhea, and weight loss. Patients with Crohn's di...
...s more likely to kill high-risk women compared to ...chers based on findings of a recent study . 8,353 ...t high risk because of diabetes or multiple risk f...ssed for three years to determine how doctors mana...
...y researchers say combining a 6 percent salicylic ...ffective treatment option for plaque psoriasis, an...y, red and thickened skin . For the study 30 adult...ed for 12 weeks. Study participants randomly recei...
... risk factors may reduce the risk of dementia, say.../ which shows that cardiovascular risk factors in ...dementia in old age. Risk factors for cardiovascu...pertension, diabetes and smoking. Each of these ca...
Other Medicine News:
...nverted microscopy from Zeiss. It has outstanding ..., with innovative condensers and optimized fluores...cated documentation and adaptation options, outsta... And Axiovert 200 M, fully motorized, gives you th...
... hallmark of these stereozoom fluorescent microsco... The top (incident) circular 9W fluorescent ring l... shadows while remaining cool to the touch. Binocu...10x to 44x zoom magnification or high-power 20x to...
...esigned for scientific microscope imaging applicat...ras provides high-resolution, full-color images an...E 1394) high-speed interface. This "live" previewi...lance and auto exposure operations to further enha...
...nce photomicrography system that greatly simply ta...t difficult specimens. Designed with real life in ...complex problem of fluorescence photomicrography. ...he system utilizes special programs designed to ea...
Medicine Products: